Unicycive Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Unicycive Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Unicycive Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $38.6M, a 98.4% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$38.6M	+$19.1M	+98.4%	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	$44.7M	+$21.8M	+95.3%	Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$52.4M	+$25.2M	+92.6%	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$14.2M	+$11.4M	+404%	Dec 31, 2023	10-Q	2024-11-13
Q3 2023	$19.4M	+$9.27M	+91%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$22.9M	+$10.1M	+78.6%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$27.2M	+$11.4M	+72.6%	Mar 31, 2023	10-Q	2023-05-16
Q4 2022	$2.82M	-$15.9M	-85%	Dec 31, 2022	10-K	2024-03-28
Q3 2022	$10.2M	-$9.61M	-48.6%	Sep 30, 2022	10-Q	2022-11-14
Q2 2022	$12.8M	+$11.9M	+1304%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$15.8M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$18.7M	+$18.5M	+9088%	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$19.8M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$913K			Jun 30, 2021	10-Q	2021-08-16
Q4 2020	$204K			Dec 31, 2020	10-K	2022-03-31

* An asterisk sign (*) next to the value indicates that the value is likely invalid.